[Antigen] COVID-19 total Ag - RAPID TEST

3 minutes - Fast result 
2 steps - Easy to use 
LIS Connectivity - Data management
 
FREND COVID-19 total Ag
The FREND™ COVID-19 Ag is a fluorescence immunoassay (FIA) for use with the FREND™ System. It is designed
for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab
specimens directly from individuals suspected with COVID-19 by their healthcare provider.
 
Clinical Performance Evaluation
The total of 109 clinical samples (34 positive and 75 negative) confirmed with RT-PCR were tested with the
FREND™ COVID-19 Ag. It shows 94.12% PPA (Positive Percent Agreement) and 100.00% NPA (Negative Percent
Agreement) as shown below.
 
Using FRENDTM System for Extension Study
Most of the rapid kits only offer tests on Serological Diagnostic Kits using IgG and IgM. 
However, the FREND System can also be used to manage and assess COVID-19 patient in secondary infection or comorbidities that could follow using the additional markers, D-dimer, Troponin I, PCT, IL-6, and CRP (C-reactive protein) through QUANTITATIVE detection.

Laboratory Information System ConnectivityIn the event of a pandemic, the management of a vastamount of clinical result is important. However, manylaboratories face the challenge in arranging theessential information effectively.
Paperless
Time-saving
Automatic Data Transfer & Collect
Convenient Data Management
Can Help Monitoring (serosurveillance)